Instead of offering standalone testing services, Cotecna increasingly works alongside customers to simplify quality processes and create measurable operational value
Amit Chopra, CEO, South Asia & Middle East
The journey of a medicine does not end when it is formulated. Before it reaches a patient, it must pass through a complex framework of scientific validation, regulatory scrutiny, and quality assurance. As pharmaceutical products become more sophisticated and global regulations continue to evolve, testing and quality assurance have emerged as strategic functions rather than compliance checkpoints. Pharmaceutical manufacturers today require partners that can combine scientific expertise, regulatory understanding, and advanced analytical capabilities to ensure every product consistently meets the highest standards of safety, efficacy, and quality.
This is where Cotecna has established its position. With a comprehensive portfolio spanning pharmaceutical testing, inspection, certification, and quality assurance, the company supports organizations throughout the product lifecycle— from early-stage development to commercialization. Under the leadership of its Chief Executive Officer for South Asia and the Middle East, Cotecna is expanding its regional capabilities while helping pharmaceutical, biotechnology, medical device, healthcare, and government organizations navigate an increasingly demanding regulatory landscape with confidence.
Beyond Compliance, Toward Scientific Confidence
In pharmaceutical testing, regulatory compliance is only one part of the equation. Manufacturers also need reliable scientific insights that enable faster decisions without compromising product quality. Cotecna has built its capabilities around this principle by offering a broad spectrum of analytical and quality assurance services that address both current and emerging industry requirements.
“Our portfolio includes analytical testing, stability studies, microbiological testing, method development and validation, elemental impurity analysis, extractables and leachables (E&L) studies, nitrosamine analysis, cleaning validation, and medical device testing. Rather than functioning as an isolated laboratory service provider, the company positions itself as an integrated quality partner supporting clients across every stage of pharmaceutical development and manufacturing”, highlights Amit Chopra, Chief Executive Officer, South Asia and Middle East, Cotecna Group.
The organization's strength lies in combining global scientific expertise with deep regulatory knowledge and advanced analytical infrastructure. This enables customers operating across regulated as well as emerging markets to meet increasingly stringent quality expectations while maintaining operational efficiency.
Building Capabilities for Tomorrow's Regulations
The pharmaceutical industry rarely stands still. Regulatory agencies continue to introduce new expectations around impurity profiling, data integrity, digital documentation, and complex therapies. The rapid emergence of biologics, advanced formulations, and evolving medical device regulations has further expanded the scope of pharmaceutical testing.
Recognizing these shifts, Cotecna has consistently invested ahead of industry demand instead of reacting after regulatory changes occur. Laboratory digitalization, automation, modern analytical platforms, and enhanced data management systems have become central to its growth strategy. Equally important has been the continued development of scientific talent and specialized regulatory expertise capable of addressing increasingly sophisticated testing requirements.
A notable example has been the industry's response to evolving global requirements surrounding nitrosamine impurities, extractables and leachables, and heightened data integ rity expectations. Meeting these standards required significant investments in advanced instrumentation, specialized scientific capabilities, regulatory training, and strengthened quality systems. By proactively expanding these capabilities, Cotecna positioned itself to support customers through complex regulatory transitions while minimizing disruptions to product development and commercialization.
The experience reinforced an important lesson that continues to guide the organization: in pharmaceutical quality assurance, agility and continuous innovation are no longer competitive advantages - they are operational necessities.
Quality Systems that Build Long-Term Trust
For pharmaceutical companies, testing results influence regulatory approvals, manufacturing decisions, and ultimately patient safety. Accuracy, consistency, and traceability therefore cannot be compromised.
Cotecna embeds quality into every stage of its operations through a comprehensive Quality Management System supported by validated methodologies, qualified scientific personnel, standardized operating procedures, continuous technical training, instrument qualification programs, internal audits, corrective and preventive action (CAPA) processes, and rigorous data integrity practices. However, sustaining long-term customer relationships requires more than technical excellence alone. Responsiveness, transparency, and consistent delivery have become equally important in an environment where development timelines continue to shrink while regulatory expectations continue to rise.
Instead of offering standalone testing services, Cotecna increasingly works alongside customers to simplify quality processes and create measurable operational valueAmit Chopra, CEO, South Asia & Middle East
“This customer-centric philosophy has also shaped the company's operational strategy across South Asia and the Middle East. Alongside expanding its testing footprint through organizations such as Geochem and Shiva Analytical, the company has focused on strengthening customer experience by developing workflow-based solutions that help organizations improve productivity while accelerating their own growth”, speaks Amit Chopra.
Instead of offering standalone testing services, Cotecna increasingly works alongside customers to simplify quality processes and create measurable operational value.
Expanding the Future of Pharmaceutical Quality
Cotecna continues to strengthen its capabilities in advanced pharmaceutical testing while expanding into areas such as medical device and biopharmaceutical testing. At the same time, it is accelerating digital transformation initiatives, enhancing laboratory automation, broadening its regional presence through strategic expansion, and exploring new partnerships that extend its service portfolio across South Asia and the Middle East.
Beyond commercial growth, Cotecna also aims to contribute to broader quality infrastructure initiatives, regulatory testing programs, and public health projects that strengthen healthcare ecosystems.
Its long-term vision extends beyond laboratory services. By combining scientific excellence, operational integrity, digital innovation, and regulatory expertise, Cotecna seeks to become a trusted quality partner supporting manufacturers, regulators, and healthcare organizations in delivering safer medicines and improving patient outcomes worldwide.
As pharmaceutical innovation accelerates and regulatory expectations continue to evolve, the organizations that will create lasting impact are those capable of transforming quality assurance from a regulatory obligation into a strategic advantage. Through sustained investment in science, technology, and customer-focused solutions, Cotecna is positioning itself to play precisely that role.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")